Associate Director, Market Access – Poland and Eastern European Countries

Description

• Who We Are

• BioMarin is a global biotechnology company that relentlessly pursues bold science to translate genetic discoveries into new medicines that advance the future of human health.

• Since our founding in 1997, we have applied our scientific expertise in understanding the underlying causes of genetic conditions to create transformative medicines, using a number of treatment modalities.

• Using our unparalleled expertise in genetics and molecular biology, we develop medicines for patients with significant unmet medical need. We enlist the best of the best – people with the right technical expertise and a relentless drive to solve real problems – and create an environment that empowers our teams to pursue bold, innovative science. With this distinctive approach to drug discovery, we’ve produced a diverse pipeline of commercial, clinical and preclinical candidates that have well-understood biology and provide an opportunity to be first-to-market or offer a substantial benefit over existing therapeutic options.

• About Commercial

• Our Commercial organization leads our global sales and marketing strategies around the world. Our integrated team continues to solidify BioMarin’s commercial presence in the United States and Europe and is rapidly growing in other regions, such as Latin America, the Middle East and Asia-Pacific.

• Position: Associate Director, Market Access – Poland and Eastern European Countries

• Location: Poland (Warsaw preferably)

• Coverage: Poland, Hungary, Baltic States, Balkans, Czechia, Slovakia, Croatia, others

• Department: Commercial Team Eastern European Countries Cluster / PAVE (Pricing, Access, Value, Evidence TEAM – Eastern and Northern Europe Market Access)

• Reports: Area Director, Eastern European Countries, dotted-line to Eastern and Northern Europe Market Access Director

Summary:

• BioMarin, a global leader in biotech medicines for Rare and Ultra‑Rare diseases, is recruiting for a SM/AD Market Access in Eastern European Countries (Poland, Czechia, Slovakia, Hungary, Bulgaria, Romania, Baltic states, Balkans, Greece, Cyprus, Malta).

• The SM/AD, Market Access – Eastern European Countries (EEC) is responsible for driving, coordinating, and executing all delegated market access–related activities across the assigned countries.

• The role ensures effective planning and implementation of market access strategies, health‑policy activities, payer engagements, early pipeline/new product planning, and cross‑functional collaboration to support BioMarin’s portfolio.

• This position works in close alignment with the ENE Market Access team, Medical Affairs, Marketing, and local Commercial teams to secure timely and sustainable access to BioMarin products for patients across diverse healthcare systems.

• Success in this role requires a highly collaborative, transparent, and solution‑oriented working style to ensure smooth coordination across Commercial and cross‑functional teams.

Responsibilities

Market Access Strategy and Execution:

• Coordinate and deliver all market access activities in the EEC region. Primary focus of activities is in Poland and other Eastern European Countries as prioritised in alignment with the EEC Commercial team and ENE Market Access leadership.
• Preparation of Pricing and Reimbursement dossiers for different archetypes of markets and health systems, such as HTA markets, budgetary‑driven markets, and Named Patient‑sales markets.
• Support national and regional reimbursement processes, pricing negotiations, and renewal cycles of contracts and named patient‑sales applications where applicable, in support of Commercial objectives.
• Ensure consistency of communication and alignment with Global, International, and ENE Market Access, and cross‑functional regional teams (Medical Affairs, Marketing, Legal, Advocacy, Government Affairs, Communications).

Payer & Stakeholder Engagement:

• Identify, map, and prioritise key national, regional, and local stakeholders across assigned countries and institutions.
• Engage with payers/ex‑payers/agencies toward preparation of HTA submissions, establishing and maintaining credible, long‑term relationships with them.
• Capture payer needs and insights to inform internal planning on evidence generation, pricing strategies, and market access.
• Directly or indirectly activate local stakeholders, including trade organisations, HCPs, medical societies, politicians, and representatives from patient advocacy organisations, to create a supportive environment for discussions on rare and ultra‑rare diseases.

Access Policy:

• Continuously monitor the health policy environment, HTA/reimbursement reforms, pricing legislation, and payer trends across the EEC.
• Liaise with relevant coalitions, trade organisations, and interest groups that operate/work in rare disease.
• Provide regular briefings and recommendations to the Regional and Global Market Access teams regarding the evolving policy landscape.
• Influence discussions on policy that benefit access to rare diseases or legitimate BioMarin interests on pricing, HTA, and access.

General responsibilities/requirements:

• Work closely with cross‑functional teams (Medical Affairs, Marketing, Legal, Advocacy, Government Affairs, Communications).
• Ensure seamless, proactive collaboration with the EEC Commercial team, maintaining continuous alignment on priorities, planning, and execution to support unified regional strategies.
• Demonstrate transparent, timely communication with all internal stakeholders, ensuring clarity, alignment, and efficient issue resolution across markets.
• Foster constructive, cross‑functional partnerships built on trust, accountability, and open dialogue.
• Provide Market Access perspective to cross‑functional brand planning, Commercial goal‑setting, scenario analysis, and strategic or tactical discussions.
• Contribute to improved positioning of key BioMarin assets in payer recommendations, treatment guidelines, and national/regional formulari